different presentations and different treatment options in blastic plasmacytoid dendritic cell neoplasms: a case series

Blastic plasmacytoid dendritic cell neoplasms (bpdcn) are rare, aggressive hematologic neoplasms. awareness about this neoplasm has increased after it was defined as a clonal plasmacytoid dendritic cell disease under histiocytic/dendritic cell neoplasms in the world health organization 2022 classification of myeloid and histiocytic/dendritic neoplasms1. therapies include chemotherapy or immunotherapy2-4 though stem cell transplantation (sct) is the best consolidative approach in eligible patients5. here, we present one intensive therapy-ineligible and two intensive-therapy-eligible patients with different presentations of bpdcn.